Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Tokyo - Delayed Quote JPY

HABA Laboratories,Inc. (4925.T)

1,685.00
-11.00
(-0.65%)
At close: 3:30:00 PM GMT+9
Loading Chart for 4925.T
  • Previous Close 1,696.00
  • Open 1,692.00
  • Bid 1,681.00 x --
  • Ask 1,699.00 x --
  • Day's Range 1,665.00 - 1,692.00
  • 52 Week Range 1,500.00 - 2,107.00
  • Volume 1,200
  • Avg. Volume 3,290
  • Market Cap (intraday) 6.372B
  • Beta (5Y Monthly) 0.16
  • PE Ratio (TTM) --
  • EPS (TTM) -473.01
  • Earnings Date May 9, 2025
  • Forward Dividend & Yield 80.00 (4.72%)
  • Ex-Dividend Date Mar 28, 2025
  • 1y Target Est --

HABA Laboratories,Inc. manufactures and sells skin care, and hair and body care products in Japan and internationally. Its skin care products include cleansers/face washes, toners, special care products, and squalane oils; and hair and body care products, such as shampoos, conditioners, hair treatment, body shampoo, hand care, and hand and body soaps products. The company sells its products through online shopping, shop sales, and drug/variety stores. It has shops located in department stores, shopping malls, etc. HABA Laboratories,Inc. was incorporated in 1976 and is headquartered in Tokyo, Japan.

www.haba.com

631

Full Time Employees

March 31

Fiscal Year Ends

Recent News: 4925.T

View More

Performance Overview: 4925.T

Trailing total returns as of 4/23/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

4925.T
4.06%
Nikkei 225 (^N225)
12.60%

1-Year Return

4925.T
14.75%
Nikkei 225 (^N225)
7.15%

3-Year Return

4925.T
12.95%
Nikkei 225 (^N225)
28.64%

5-Year Return

4925.T
55.97%
Nikkei 225 (^N225)
79.46%

Compare To: 4925.T

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 4925.T

View More

Valuation Measures

Annual
As of 4/22/2025
  • Market Cap

    6.41B

  • Enterprise Value

    4.70B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.52

  • Price/Book (mrq)

    0.77

  • Enterprise Value/Revenue

    0.38

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -8.02%

  • Return on Assets (ttm)

    2.87%

  • Return on Equity (ttm)

    -10.79%

  • Revenue (ttm)

    12.3B

  • Net Income Avi to Common (ttm)

    -986M

  • Diluted EPS (ttm)

    -473.01

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.01B

  • Total Debt/Equity (mrq)

    24.65%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 4925.T

View More

Company Insights: 4925.T

Research Reports: 4925.T

View More

People Also Watch